TMDX Q1 2021 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M-6.3% YoY

Gross Profit

$5M68.2% margin

Operating Income

-$7M-92.3% margin

Net Income

-$8M-112.3% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

-7.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$146M

Total Liabilities

$48M

Stockholders' Equity

$98M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$8M	-6.3%
Gross Profit	$5M	$5M	-1.0%
Operating Income	-$7M	-$8M	+18.8%
Net Income	-$8M	-$9M	+10.6%

Revenue Segments

Ocs Heart Product

$4M59%

Ocs Lung Product

$2M34%

Ocs Liver Product

$442,0006%

Geographic Segments

UNITED STATES

$6M87%

Non Us And Uk

$824,00013%